Some of the most meaningful guidance comes from people who truly understand the experience. During the 20th Annual Symposium on Pancreatic Cancer, Jeanette Reedy Solano, cancer-free for over a year, […]
FDA Expands Access to Daraxonrasib: What Patients Need to Know
The FDA has granted permission for Revolution Medicines to provide access to its investigational RAS inhibitor, daraxonrasib, through an Expanded Access Program (EAP) for certain patients with metastatic pancreatic ductal […]
pNET Treatments and Emerging Research
As an overview of Pancreatic Neuroendocrine Tumors, we look at the current standard treatment for pNETs and what emerging therapies are on the horizon. Also discussed is the translational research […]
New Free Program Offers Support and Practical Tools for Cancer Caregivers in California
Caring for a loved one diagnosed with cancer can be both meaningful and overwhelming. Many caregivers find themselves juggling medical appointments, insurance paperwork, work responsibilities, parenting, and household needs — […]
What is a Pancreatic Neuroendocrine Tumor (pNET)?
Pancreatic neuroendocrine tumors, also called pNETs or PanNETs, are the second most common type of pancreatic tumor, representing up to 2% of all pancreatic cancer cases. pNETs are distinct from […]
A Gift of Comfort for Pancreatic Cancer Patients, Our Partnership with Talking Angels Foundation
To a newly diagnosed cancer patient, a blanket can feel like a small shield against a world that suddenly feels unpredictable. The gift of a blanket can signal that someone […]